Search
for
Sort by
Research 541–570 of 1000+
- Testosterone therapy for transgender men
- Metabolic risk in PCOS: phenotype and adiposity impact
- An Update of Congenital Adrenal Hyperplasia
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Dermatology of androgen-related disorders
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Overactivated sonic hedgehog signaling aggravates intrauterine adhesion via inhibiting autophagy in endometrial stromal cells
- The therapeutic use of androgens in women
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
- Hormonal treatment of acne vulgaris: an update
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Evidence-based approach to cutaneous hyperandrogenism in women
- A Mouse Model of Androgenetic Alopecia
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles <i>in vitro</i>
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review